Coronavirus (COVID-19) Replace: FDA Authorizes Moderna and Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as Booster Doses in Youthful Age Teams

For fast publication: October 12, 2022 English Immediately, the U.S. Meals and Drug Administration amended the emergency use authorizations (EUAs) for the Moderna bivalent COVID-19 vaccine and the Pfizer-BioNTech bivalent COVID-19 vaccine to authorize use as a single booster dose in youthful age teams. The Moderna COVID-19, bivalent vaccine is licensed for administration at the …

Coronavirus (COVID-19) Replace: FDA Authorizes Moderna and Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as Booster Doses in Youthful Age Teams Read More »